| cardiac muscle tissue development | GO:0048738 | 130 | 0.756 | |
| circulatory system process | GO:0003013 | 197 | 0.663 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.650 | |
| blood circulation | GO:0008015 | 195 | 0.605 | |
| muscle tissue development | GO:0060537 | 308 | 0.528 | |
| striated muscle contraction | GO:0006941 | 45 | 0.497 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.481 | |
| regulation of system process | GO:0044057 | 200 | 0.429 | |
| muscle cell development | GO:0055001 | 133 | 0.389 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.367 | |
| striated muscle cell development | GO:0055002 | 125 | 0.363 | |
| heart contraction | GO:0060047 | 93 | 0.355 | |
| muscle contraction | GO:0006936 | 101 | 0.346 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.336 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.322 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.306 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.298 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.285 | |
| response to inactivity | GO:0014854 | 4 | 0.281 | |
| heart morphogenesis | GO:0003007 | 178 | 0.273 | |
| muscle system process | GO:0003012 | 141 | 0.262 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.246 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.245 | |
| heart process | GO:0003015 | 94 | 0.231 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.228 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.210 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.210 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.207 | |
| rhythmic process | GO:0048511 | 174 | 0.203 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.201 | |
| muscle fiber development | GO:0048747 | 76 | 0.199 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.197 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.196 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.193 | |
| maintenance of location | GO:0051235 | 89 | 0.189 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.183 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.179 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.177 | |
| organelle assembly | GO:0070925 | 177 | 0.172 | |
| lipid localization | GO:0010876 | 126 | 0.170 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.165 | |
| cation transport | GO:0006812 | 399 | 0.155 | |
| calcium ion transport | GO:0006816 | 159 | 0.150 | |
| cation homeostasis | GO:0055080 | 212 | 0.148 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.147 | |
| positive regulation of blood circulation | GO:1903524 | 22 | 0.144 | |
| protein localization to organelle | GO:0033365 | 185 | 0.143 | |
| oxidation reduction process | GO:0055114 | 342 | 0.142 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.141 | |
| neuromuscular process | GO:0050905 | 99 | 0.141 | |
| lipid storage | GO:0019915 | 36 | 0.139 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.138 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.138 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.136 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.133 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.132 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.129 | |
| amine metabolic process | GO:0009308 | 45 | 0.128 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.128 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.126 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.124 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.123 | |
| cell adhesion | GO:0007155 | 329 | 0.123 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.123 | |
| negative regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061179 | 4 | 0.122 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.121 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.120 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.119 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.119 | |
| regulation of ion transport | GO:0043269 | 215 | 0.118 | |
| locomotory behavior | GO:0007626 | 195 | 0.118 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.116 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.112 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.110 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.109 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.108 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.107 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.106 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.106 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.106 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.103 | |
| angiogenesis | GO:0001525 | 201 | 0.099 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.098 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.098 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.097 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.097 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.096 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.091 | |
| hexose metabolic process | GO:0019318 | 98 | 0.091 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.089 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.088 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.088 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.087 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.087 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.087 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.085 | |
| regulation of skeletal muscle contraction | GO:0014819 | 3 | 0.083 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.083 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.082 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.082 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.080 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.079 | |
| cell recognition | GO:0008037 | 83 | 0.078 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.077 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.076 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.075 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.075 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.075 | |
| mitochondrion organization | GO:0007005 | 134 | 0.074 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.074 | |
| regulation of sarcomere organization | GO:0060297 | 4 | 0.073 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.073 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.073 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.072 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.072 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.072 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.071 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.069 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.068 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.068 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.068 | |
| intracellular protein transport | GO:0006886 | 204 | 0.068 | |
| ovulation cycle | GO:0042698 | 59 | 0.067 | |
| sarcomere organization | GO:0045214 | 24 | 0.067 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.067 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.067 | |
| cardiac chamber development | GO:0003205 | 108 | 0.066 | |
| response to peptide hormone | GO:0043434 | 127 | 0.065 | |
| cytokine production | GO:0001816 | 319 | 0.064 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.063 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.063 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.062 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.062 | |
| regulation of inward rectifier potassium channel activity | GO:1901979 | 1 | 0.061 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.060 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.060 | |
| cellular homeostasis | GO:0019725 | 240 | 0.059 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.059 | |
| skeletal muscle adaptation | GO:0043501 | 16 | 0.058 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.058 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.058 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.058 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.056 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.055 | |
| protein targeting | GO:0006605 | 143 | 0.055 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.055 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.055 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.054 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.054 | |
| glucose homeostasis | GO:0042593 | 128 | 0.053 | |
| myotube cell development | GO:0014904 | 60 | 0.053 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.053 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.053 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.052 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.052 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.052 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.052 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.051 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.051 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.050 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.050 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.050 | |
| regulation of atp catabolic process | GO:1903289 | 9 | 0.050 | |
| histone modification | GO:0016570 | 159 | 0.050 | |
| transmembrane transport | GO:0055085 | 412 | 0.049 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.048 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.048 | |
| membrane organization | GO:0061024 | 245 | 0.048 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.048 | |
| response to muscle inactivity | GO:0014870 | 4 | 0.048 | |
| circadian rhythm | GO:0007623 | 114 | 0.048 | |
| myotube differentiation | GO:0014902 | 105 | 0.048 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.047 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.047 | |
| cardiac cell development | GO:0055006 | 41 | 0.046 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.046 | |
| calcium ion transport from endoplasmic reticulum to cytosol | GO:1903514 | 12 | 0.046 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.045 | |
| chromatin organization | GO:0006325 | 206 | 0.045 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.045 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.044 | |
| connective tissue development | GO:0061448 | 179 | 0.044 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.044 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.044 | |
| regulation of heart rate | GO:0002027 | 36 | 0.044 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.044 | |
| cellular response to testosterone stimulus | GO:0071394 | 1 | 0.043 | |
| glucose metabolic process | GO:0006006 | 92 | 0.043 | |
| dna metabolic process | GO:0006259 | 303 | 0.043 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.042 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.042 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.042 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.042 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.042 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.041 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.041 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.041 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.041 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.041 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.041 | |
| myofibril assembly | GO:0030239 | 34 | 0.040 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.040 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.040 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.040 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.040 | |
| stem cell differentiation | GO:0048863 | 268 | 0.039 | |
| multi organism behavior | GO:0051705 | 62 | 0.039 | |
| chromatin modification | GO:0016568 | 187 | 0.038 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.038 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.038 | |
| muscle adaptation | GO:0043500 | 39 | 0.038 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.038 | |
| myosin filament assembly | GO:0031034 | 2 | 0.038 | |
| ossification | GO:0001503 | 216 | 0.038 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.038 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.037 | |
| response to oxygen levels | GO:0070482 | 62 | 0.037 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.037 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.037 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.037 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.037 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.037 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.036 | |
| response to nutrient levels | GO:0031667 | 109 | 0.035 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.035 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.035 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.035 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.035 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.035 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.034 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.034 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.034 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.034 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.033 | |
| extracellular structure organization | GO:0043062 | 148 | 0.033 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.033 | |
| regulation of secretion | GO:0051046 | 274 | 0.033 | |
| myosin filament organization | GO:0031033 | 3 | 0.033 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.033 | |
| regulation of circadian sleep wake cycle rem sleep | GO:0042320 | 1 | 0.033 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.033 | |
| nuclear transport | GO:0051169 | 139 | 0.033 | |
| female sex differentiation | GO:0046660 | 84 | 0.032 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.032 | |
| developmental maturation | GO:0021700 | 193 | 0.032 | |
| adult behavior | GO:0030534 | 135 | 0.032 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.032 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.031 | |
| regulation of relaxation of muscle | GO:1901077 | 8 | 0.031 | |
| cellular response to starvation | GO:0009267 | 57 | 0.031 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.031 | |
| atp catabolic process | GO:0006200 | 55 | 0.031 | |
| organelle fission | GO:0048285 | 170 | 0.030 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.030 | |
| regulation of protein stability | GO:0031647 | 52 | 0.030 | |
| response to inorganic substance | GO:0010035 | 96 | 0.030 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.030 | |
| rna processing | GO:0006396 | 105 | 0.030 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.029 | |
| t cell proliferation | GO:0042098 | 120 | 0.029 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.029 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.029 | |
| learning or memory | GO:0007611 | 148 | 0.029 | |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.029 | |
| b cell differentiation | GO:0030183 | 78 | 0.029 | |
| cellular modified amino acid biosynthetic process | GO:0042398 | 12 | 0.028 | |
| t cell activation | GO:0042110 | 289 | 0.028 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.028 | |
| jak stat cascade | GO:0007259 | 42 | 0.028 | |
| cellular response to food | GO:0071240 | 1 | 0.028 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.028 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.028 | |
| embryonic placenta development | GO:0001892 | 98 | 0.028 | |
| response to testosterone | GO:0033574 | 3 | 0.028 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.028 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.028 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.028 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.028 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.028 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.028 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.028 | |
| mrna processing | GO:0006397 | 63 | 0.028 | |
| response to alcohol | GO:0097305 | 48 | 0.027 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.027 | |
| gland development | GO:0048732 | 330 | 0.027 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.027 | |
| response to insulin | GO:0032868 | 100 | 0.027 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.027 | |
| regulation of atpase activity | GO:0043462 | 9 | 0.027 | |
| atp metabolic process | GO:0046034 | 75 | 0.027 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.027 | |
| regulation of protein localization | GO:0032880 | 231 | 0.026 | |
| skeletal muscle myosin thick filament assembly | GO:0030241 | 1 | 0.026 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.026 | |
| lipid transport | GO:0006869 | 98 | 0.026 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.026 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.026 | |
| skeletal system development | GO:0001501 | 356 | 0.026 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.026 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.026 | |
| microtubule based process | GO:0007017 | 236 | 0.026 | |
| endoplasmic reticulum to cytosol transport | GO:1903513 | 12 | 0.026 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.025 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.025 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.025 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.025 | |
| cognition | GO:0050890 | 149 | 0.025 | |
| cellular response to lipid | GO:0071396 | 145 | 0.025 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.025 | |
| drug metabolic process | GO:0017144 | 4 | 0.025 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.025 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.024 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.024 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.024 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.024 | |
| immune effector process | GO:0002252 | 321 | 0.024 | |
| myoblast differentiation | GO:0045445 | 52 | 0.024 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.024 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.024 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.024 | |
| response to starvation | GO:0042594 | 65 | 0.024 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.023 | |
| hormone secretion | GO:0046879 | 128 | 0.023 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.023 | |
| cartilage development | GO:0051216 | 140 | 0.023 | |
| pallium development | GO:0021543 | 120 | 0.023 | |
| regulation of satellite cell proliferation | GO:0014842 | 5 | 0.023 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.023 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.023 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.023 | |
| action potential | GO:0001508 | 78 | 0.023 | |
| cell fate commitment | GO:0045165 | 210 | 0.023 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.022 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.022 | |
| learning | GO:0007612 | 98 | 0.022 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.022 | |
| interleukin 12 secretion | GO:0072610 | 3 | 0.022 | |
| regulation of cell activation | GO:0050865 | 289 | 0.022 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.022 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.022 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.022 | |
| mrna metabolic process | GO:0016071 | 84 | 0.022 | |
| t helper 2 cell cytokine production | GO:0035745 | 4 | 0.022 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.022 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.022 | |
| response to muscle inactivity involved in regulation of muscle adaptation | GO:0014877 | 4 | 0.022 | |
| response to activity | GO:0014823 | 13 | 0.021 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.021 | |
| mitral valve development | GO:0003174 | 4 | 0.021 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.021 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.021 | |
| myotube differentiation involved in skeletal muscle regeneration | GO:0014908 | 2 | 0.021 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.021 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.021 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.021 | |
| cell division | GO:0051301 | 120 | 0.021 | |
| endocytosis | GO:0006897 | 168 | 0.021 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.021 | |
| cerebral cortex development | GO:0021987 | 86 | 0.021 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.021 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.021 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.021 | |
| regulation of g protein activated inward rectifier potassium channel activity | GO:1900128 | 1 | 0.021 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.021 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.020 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.020 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.020 | |
| actin filament based movement | GO:0030048 | 23 | 0.020 | |
| sclerotome development | GO:0061056 | 4 | 0.020 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.020 | |
| amide transport | GO:0042886 | 138 | 0.020 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.020 | |
| notch signaling pathway | GO:0007219 | 71 | 0.020 | |
| defense response to bacterium | GO:0042742 | 119 | 0.020 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.020 | |
| response to heat | GO:0009408 | 27 | 0.020 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.019 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.019 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.019 | |
| cytokinetic process | GO:0032506 | 2 | 0.019 | |
| negative regulation of binding | GO:0051100 | 39 | 0.019 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.019 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.019 | |
| protein import | GO:0017038 | 101 | 0.019 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.019 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.019 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.019 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.019 | |
| left ventricular cardiac muscle tissue morphogenesis | GO:0003220 | 2 | 0.019 | |
| response to denervation involved in regulation of muscle adaptation | GO:0014894 | 4 | 0.019 | |
| telencephalon development | GO:0021537 | 186 | 0.018 | |
| rna interference | GO:0016246 | 2 | 0.018 | |
| detection of mechanical stimulus | GO:0050982 | 27 | 0.018 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.018 | |
| tube closure | GO:0060606 | 91 | 0.018 | |
| membrane invagination | GO:0010324 | 17 | 0.018 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.018 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.018 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.018 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.018 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.018 | |
| cell cycle switching | GO:0060184 | 1 | 0.018 | |
| baroreceptor response to decreased systemic arterial blood pressure | GO:0001982 | 2 | 0.018 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.018 | |
| mitochondrial transport | GO:0006839 | 36 | 0.018 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.018 | |
| regulation of atp metabolic process | GO:1903578 | 17 | 0.018 | |
| regulation of binding | GO:0051098 | 111 | 0.018 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.018 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.018 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.018 | |
| response to metal ion | GO:0010038 | 47 | 0.018 | |
| response to growth factor | GO:0070848 | 198 | 0.018 | |
| synaptic transmission | GO:0007268 | 329 | 0.017 | |
| placenta development | GO:0001890 | 140 | 0.017 | |
| respiratory tube development | GO:0030323 | 167 | 0.017 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.017 | |
| fertilization | GO:0009566 | 127 | 0.017 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.017 | |
| somite development | GO:0061053 | 81 | 0.017 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.017 | |
| histone acetylation | GO:0016573 | 41 | 0.017 | |
| relaxation of muscle | GO:0090075 | 18 | 0.017 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.017 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.017 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.017 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.017 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.017 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.017 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.017 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.017 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.017 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.017 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.017 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.017 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.017 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.016 | |
| norepinephrine transport | GO:0015874 | 2 | 0.016 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.016 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.016 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.016 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.016 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 23 | 0.016 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.016 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.016 | |
| regulation of jak stat cascade | GO:0046425 | 34 | 0.016 | |
| camera type eye development | GO:0043010 | 266 | 0.016 | |
| nuclear division | GO:0000280 | 158 | 0.016 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.016 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.016 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.016 | |
| tissue homeostasis | GO:0001894 | 115 | 0.016 | |
| l glutamate import into cell | GO:1990123 | 3 | 0.016 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.016 | |
| cell cycle switching mitotic to meiotic cell cycle | GO:0051728 | 1 | 0.016 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.016 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.016 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.016 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.016 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.016 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.016 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.016 | |
| defense response to other organism | GO:0098542 | 197 | 0.016 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.015 | |
| neurological system process involved in regulation of systemic arterial blood pressure | GO:0001976 | 18 | 0.015 | |
| response to muscle stretch | GO:0035994 | 1 | 0.015 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.015 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.015 | |
| regulation of endothelial cell proliferation | GO:0001936 | 23 | 0.015 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.015 | |
| nuclear import | GO:0051170 | 95 | 0.015 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.015 | |
| negative regulation of hormone secretion | GO:0046888 | 20 | 0.015 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.015 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.015 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.015 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.015 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.015 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.015 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.015 | |
